Source: Current Atherosclerosis Reports. Unidades: FCF, FM
Subjects: DOENÇAS VASCULARES, FARMACOTERAPIA
ABNT
MARINHO, Lucas Lage et al. Impact of selective peroxisome proliferator-activated receptor (PPAR)-α modulators and fibrates on microvascular disease: is there still room?. Current Atherosclerosis Reports, v. 27, p. 1-14 art. 39, 2025Tradução . . Disponível em: https://dx.doi.org/10.1007/s11883-025-01292-0. Acesso em: 12 jun. 2025.APA
Marinho, L. L., Ribeiro, M. L., Lawler, P. R., Iatan, I., Godoy, L. C., Rached, F. H., & Maranhão, R. C. (2025). Impact of selective peroxisome proliferator-activated receptor (PPAR)-α modulators and fibrates on microvascular disease: is there still room? Current Atherosclerosis Reports, 27, 1-14 art. 39. doi:10.1007/s11883-025-01292-0NLM
Marinho LL, Ribeiro ML, Lawler PR, Iatan I, Godoy LC, Rached FH, Maranhão RC. Impact of selective peroxisome proliferator-activated receptor (PPAR)-α modulators and fibrates on microvascular disease: is there still room? [Internet]. Current Atherosclerosis Reports. 2025 ; 27 1-14 art. 39.[citado 2025 jun. 12 ] Available from: https://dx.doi.org/10.1007/s11883-025-01292-0Vancouver
Marinho LL, Ribeiro ML, Lawler PR, Iatan I, Godoy LC, Rached FH, Maranhão RC. Impact of selective peroxisome proliferator-activated receptor (PPAR)-α modulators and fibrates on microvascular disease: is there still room? [Internet]. Current Atherosclerosis Reports. 2025 ; 27 1-14 art. 39.[citado 2025 jun. 12 ] Available from: https://dx.doi.org/10.1007/s11883-025-01292-0